OOIR: Observatory of International Research

Papers

(The TQCC of Archiv der Pharmazie is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Thiazole‐based SARS‐CoV‐2 protease (COV M^pro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	69
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	55
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	49
Review on the pharmacological effects and pharmacokinetics of scutellarein	49
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	47
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin	46
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone Deacetylases	46
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	43
Cover Picture: Arch Pharm (1/2024)	42
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	41
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	41
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	38
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	35
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	31
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	31
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	30
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	30
Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability	30
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	29
Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics	29
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	29
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	27
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	27
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	25
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	25

Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)	25
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	23
Piperlongumine and its derivatives against cancer: A recent update and future prospective	22
	22
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach	21
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K_V7 channel openers: Exploration of a nicotinamide scaffold	21
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents	21
The Therapeutic Potential of Berberine in Lung Cancer	20
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors	20
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease	20
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory	20
Cover Picture: Arch Pharm (7/2023)	20
Aromatic linker variations in novel dopamine D₂ and D₃ receptor ligands	19
Editorial Board: Arch Pharm (10/2023)	19
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study	19
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors	18
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway	18
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells	18
Issue Information: Arch Pharm (5/2025)	18
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & Noë) Grierson using network pharmacology	18
	18
Cover Picture: Arch Pharm (2/2024)	18
Green Synthetic Strategies for Pyrazole Derivatives: A Comprehensive Review	17
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors	17
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity	17
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H₂O₂‐treated HDF cells of the extracts of Stachys tundjeliensis	16
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies	16
Structural determinants of sphingosine‐1‐phosphate receptor selectivity	16
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond	16
New chimeric HDAC inhibitors for the treatment of colorectal cancer	16
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis	16
Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease	15
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies	15
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells	15
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential	15
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	15
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors	15
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	15
Piperazine‐based P2X4 receptor antagonists	14
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs	14
Synthesis, Characterization and Evaluation of Antioxidant and Antimicrobial Activities of Novel Isatin Derivatives	14
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation	14
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	14
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines	14
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl₂: Anticancer, docking, and DFT studies	14
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	14
Cover Picture: Arch Pharm (6/2022)	14
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects	14
	14
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents	14

Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	14
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives	13
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	13
	13
Cover Picture: Arch Pharm (6/2023)	13
Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis	13
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates	13
	13
Issue Information: Arch Pharm (4/2025)	13
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	13
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	13
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer	13
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation	13
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity	13
	13
Synthesis and evaluation of novel almazole D analogs as anticancer agents	13
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	13
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis	12
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens	12
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study	12
Biology‐oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors	12
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs	12
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction	12
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management	12
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively	12
Up‐to‐date studies regarding the determination of melatonin by chromatographic methods	12
Design, Synthesis, and Molecular Evaluation of S_NAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode	12
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles	11
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives	11
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives	11
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	11
Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏	11
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	11
A new series of hydrazones as small‐molecule aldose reductase inhibitors	11
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency	11
Current Landscape of Hydroxamic Acid Hybrids With Anti‐Colorectal Cancer Potential	11
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	11
A Multifaceted Mechanistic Approach to Assess the Inhibitory Potential of Broccoli‐Derived Glucosinolates Against Tumor‐Associated Carbonic Anhydrase IX	11
	11
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review	11
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	11
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA	10
	10
A virtual library of small molecules mimicking dipeptides	10
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies	10
Inhibitory effects of 190 compounds against SARS‐CoV‐2 M^pr^o protein: Molecular docking interactions	10
Structural Advances in Non‐Sulfonamide Carbonic Anhydrase Inhibitors: Insights Into Design, Bioactivity, and Binding Mechanism	10
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency	10
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	10
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)	10
Issue Information: Arch Pharm (4/2024)	10
Тhio‐containing pteridines: Synthesis, modification, and biological activity	10
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors	10
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture	10
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents	10
Health benefits of fraxetin: From chemistry to medicine	10
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth	10
Editorial Board: Arch Pharm (9/2023)	10
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration	10
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors	10
New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations	10
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability	9
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking	9
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells	9
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents	9
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies	9
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives	9
Issue Information: Arch Pharm (12/2024)	9
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies	9
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors	9
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct	9
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	9
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats	9
Ginkgo biloba in the management of the COVID‐19 severity	9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases	9
Various pharmacological agents in the pipeline against intractable epilepsy	9
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists	9
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells	9
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment	9

Issue Information: Arch Pharm (1/2025)	9
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)	9
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors	9
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	9
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors	8
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents	8
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	8
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives	8
	8
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	8
The anti‐breast cancer potential of indole/isatin hybrids	8
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation	8
A review of recent advances in anticancer activity and SAR of pyrazole derivatives	8
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review	8
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities	8
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	8
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system	8
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions	8
Combating Drug‐Resistant Protozoal Infections: A Review of Emerging Therapeutics	8
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	8
Structure Characterization and Antibacterial, Antifungal, and Antiquorum‐Sensing Activity of New Metabolites From the Lipophilic Fractions of Platycodon grandiflorum	8
Editorial Board: Arch Pharm (9/2022)	8
Cover Picture: Arch Pharm (3/2022)	8
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review	8
Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction	8
	8
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors	8
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes	8
Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl‐Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis‐Inducing Cancer Treatment	8
Cover Picture: Arch Pharm (1/2022)	8
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies	8
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF^V600E with promising antiproliferative properties	7
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats	7
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors	7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents	7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors	7
Cover Picture: Arch Pharm (8/2023)	7
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	7
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation	7
Quinolinone Derivatives Suppress Angiogenesis in Human Umbilical Vein Endothelial Cells by Blocking the VEGF‐Induced VEGFR2 Signaling Pathway	7
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19	7
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells	7
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks	7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	7
Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity	7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases	7
Editorial Board: Arch Pharm (6/2022)	7
	7
Revealing a Gold Mine of Bioactive Compounds From Natural Sources Using In Vitro, In Silico, and Network Pharmacology: A Case Study on Cachrys cristata	7
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator	7
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments	7
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation	7
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules	7
Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”	7
Cover Picture: Arch Pharm (10/2023)	7
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway	7
Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential	7
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection	7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway	7
The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?	6
Recent advances in the development of celecoxib analogs as anticancer agents: A review	6
Enhancing Polyacrylonitrile Nanofibers Antiviral Activity Using Greenly Synthesized Silver Nanoparticles	6
Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells	6
Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti‐cardiac fibrosis activity	6
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review	6
TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects	6
Chicoric acid alleviates rotenone‐induced motor dysfunction in mice: Targeting PI3K/AKT/caspase‐3‐associated apoptosis and neuroinflammation	6
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate	6
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B	6
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease	6
Cover Picture: Arch Pharm (9/2023)	6
Exploring Micellar Systems for Intra‐Articular Delivery of Vanillic Acid in Management of Osteoarthritis	6
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	6
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment	6
SiteMine: Large‐scale binding site similarity searching in protein structure databases	6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents	6
Anti‐inflammatory activity of pyridazinones: A review	6
Radiosynthesis and whole‐body distribution in mice of a ¹⁸F‐labeled azepino[4,3‐b]indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease	6
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors	6
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors	6
Facile one‐pot synthesis of N‐pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug‐resistant Staphylococcus aureus	6
6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies	6
Synthesis of vanillin derivatives with 1,2,3‐triazole fragments and evaluation of their fungicide and fungistatic activities	6
Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents	6
Emerging Coumestans in Cancer Therapy With Mechanistic Insights and Clinical Potential	6
The anti‐Acinetobacter baumannii therapeutic potential of azole hybrids: A mini‐review	6
Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease	6
Potential of triazines in Alzheimer's disease: A versatile privileged scaffold	6
2,2,2‐Trifluoroethanol‐mediated hydroarylation of fluorinated alkynes with indoles: Application to diindolylmethanes	6
Unraveling the chemical profile, antioxidant, enzyme inhibitory, cytotoxic potential of different extracts from Astragalus caraganae	6
	6
The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study	6
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments	6
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies	6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	6